1-2 of 2
Congfen Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HGF as a Circulating Biomarker of Onartuzumab Treatment in Patients with Advanced Solid Tumors

Free
Elicia Penuel, Congfen Li, Vaishali Parab, Luciana Burton, Kyra J. Cowan, Mark Merchant, Robert L. Yauch, Premal Patel, Amy Peterson, Garret M. Hampton, Mark R. Lackner, Priti S. Hegde
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (6): 1122–1130.
https://doi.org/10.1158/1535-7163.MCT-13-0015
Published: 09 June 2013
View articletitled, HGF as a Circulating Biomarker of Onartuzumab Treatment in Patients with Advanced Solid Tumors
Open the PDF for HGF as a Circulating Biomarker of Onartuzumab Treatment in Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake

Free
Yonglei Shang, Yifan Mao, Jennifer Batson, Suzie J. Scales, Gail Phillips, Mark R. Lackner, Klara Totpal, Simon Williams, Jihong Yang, Zhijun Tang, Zora Modrusan, Christine Tan, Wei-Ching Liang, Siao Ping Tsai, Alexander Vanderbilt, Kenji Kozuka, Klaus Hoeflich, Janet Tien, Sarajane Ross, Congfen Li, Sang Hoon Lee, An Song, Yan Wu, Jean-Philippe Stephan, Avi Ashkenazi, Jiping Zha
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (9): 2599–2608.
https://doi.org/10.1158/1535-7163.MCT-07-2401
Published: 11 September 2008
View articletitled, Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Open the PDF for Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake in another window
Includes: Supplementary data